Publications by authors named "Renee Leduc"

Claim this Profile
W
What Goes Around Can Come Around: An Unexpected Deleterious Effect of Using Mouse Running Wheels for Environmental Enrichment.
Renee Y M Leduc, Gail Rauw, Glen B Baker, Heather E McDermid

J Am Assoc Lab Anim Sci· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic backgrounds and modifier genes of NTD mouse models: An opportunity for greater understanding of the multifactorial etiology of neural tube defects.
Renee Y M Leduc, Parmveer Singh, Heather E McDermid

Birth Defects Res· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The informational needs of patients with ANCA-associated vasculitis-development of an informational needs questionnaire.
Janice Mooney, Nicola Spalding, Fiona Poland, Peter Grayson, Renee Leduc

Rheumatology (Oxford)· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Causal attributions about disease onset and relapse in patients with systemic vasculitis.
Peter C Grayson, Naomi A Amudala, Carol A McAlear, Renée L Leduc, Denise Shereff

J Rheumatol· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Illness perceptions and fatigue in systemic vasculitis.
Peter C Grayson, Naomi A Amudala, Carol A Mcalear, Renée L Leduc, Denise Shereff

Arthritis Care Res (Hoboken)· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Strain-specific modifier genes of Cecr2-associated exencephaly in mice: genetic analysis and identification of differentially expressed candidate genes.
Megan K Kooistra, Renee Y M Leduc, Christine E Dawe, Nicholas A Fairbridge, Jay Rasmussen

Physiol Genomics· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extracts of Canadian first nations medicinal plants, used as natural products, inhibit neisseria gonorrhoeae isolates with different antibiotic resistance profiles.
Paulina Cybulska, Sidharath D Thakur, Brian C Foster, Ian M Scott, Renée I Leduc

Sex Transm Dis· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of 18F-FDG PET/CT imaging in Waldenstrom macroglobulinemia.
Ranjit Banwait, Kevin O'Regan, Federico Campigotto, Brianna Harris, Dilek Yarar, Renee Leduc

Am J Hematol· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of serum immunoglobulin free light chain in response and progression in waldenstrom macroglobulinemia.
Xavier Leleu, Wanling Xie, Meghan Bagshaw, Ranjit Banwait, Renee Leduc

Clin Cancer Res· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Weekly bortezomib in combination with temsirolimus in relapsed or relapsed and refractory multiple myeloma: a multicentre, phase 1/2, open-label, dose-escalation study.
Irene M Ghobrial, Edie Weller, Ravi Vij, Nikhil C Munshi, Ranjit Banwait, Renee Leduc

Lancet Oncol· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II trial of weekly bortezomib in combination with rituximab in untreated patients with Waldenström Macroglobulinemia.
Irene M Ghobrial, Wanling Xie, Swaminathan Padmanabhan, Ashraf Badros, Meghan Rourke, Renee Leduc

Am J Hematol· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II trial of weekly bortezomib in combination with rituximab in relapsed or relapsed and refractory Waldenstrom macroglobulinemia.
Irene M Ghobrial, Fangxin Hong, Swaminathan Padmanabhan, Ashraf Badros, Meghan Rourke, Renee Leduc

J Clin Oncol· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II trial of the oral mammalian target of rapamycin inhibitor everolimus in relapsed or refractory Waldenstrom macroglobulinemia.
Irene M Ghobrial, Morie Gertz, Betsy Laplant, John Camoriano, Suzanne Hayman, Renee Leduc

J Clin Oncol· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and translational studies of a phase II trial of the novel oral Akt inhibitor perifosine in relapsed or relapsed/refractory Waldenstrom's macroglobulinemia.
Irene M Ghobrial, Aldo Roccaro, Fangxin Hong, Edie Weller, Nancy Rubin, Renee Leduc

Clin Cancer Res· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum immunoglobulin free light chain correlates with tumor burden markers in Waldenstrom macroglobulinemia.
Xavier Leleu, Anne-Sophie Moreau, Edie Weller, Aldo M Roccaro, ValéRie Coiteux, Renee Leduc

Leuk Lymphoma· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel agents in the treatment of Waldenström's macroglobulinemia.
Steven P Treon, Evdoxia Hatjiharissi, Xavier Leleu, Anne-Sophie Moreau, Aldo Roccaro, Renee Leduc

Clin Lymphoma Myeloma· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis